Ulta Expands Intimate Wellness with PlusOne, Broadening Growth Opportunity
Jul 28, 2026, 9:01 AM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Direct exposure to a fast-growing, mainstream sexual-wellness line via Ulta can lift guest traffic and mix. The partnership leverages Ulta's wellness-centric framework and mass-market distribution, potentially driving incremental revenue; however, it depends on execution, pricing, and cannibalization risks within the wellness category.
AI summary
What happened, with direct paths to the underlying reporting
Ulta Beauty is adding plusOne, Beacon Wellness Brands' sexual-wellness line, to its Wellness by Ulta Beauty spaces, signaling a meaningful shift into intimate wellness. Backed by growing mass-market distribution for plusOne (Walmart, Target, CVS, Walgreens) and a broader trend toward holistic wellness, the move could broaden Ulta's wellness mix and attract new customers.
PlusOne to enter Ulta Beauty, expanding intimate-wellness distribution.
Ulta shelves plusOne in Wellness by Ulta Beauty, aligning with holistic wellness.
Market for sexual wellness forecast to reach $274B by 2035.
Ulta expects 80% of guests view wellness holistically.
PlusOne aims to normalize intimate wellness via mass-market retailers.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Ulta Beauty posted a strong first-quarter performance, with net sales rising 11.1% to $3.2B and comparable-store sales up 5.3%. The Space NK acquisition and ongoing store growth s…
Ulta Beauty's shares plummeted over 14% due to disappointing earnings results, leading to current sideways trading. The market's reaction reflects investor concerns regarding futu…
Ulta Beauty reported Q4 earnings that missed EPS expectations but surpassed revenue estimates, causing shares to fall 8%. The company's projections for net sales growth and EPS in…